Tyra Biosciences Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TYRA

Logo grafis tyra.bio (TYRA)

Management's expertise in molecular modeling drives the upward trend, where EBITDA demonstrates growth dynamics. This is supported by the SNAP platform for combating resistance and massive demand for next-generation inhibitors. The value of 0.00 reflects the latest metric value, capturing the current financial result of the commercial activities of Tyra Biosciences, Inc. (TYRA).

Tyra Bio - Bathi operasional EBITDA TYRA (periode 23.11.2025 - 14.11.2026)

Tyra Biosciences (TYRA) - rincian metrik lan laporan keuangan

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:Tyra Biosciences, Inc.
Produk merek Tyra Biosciences

The indicator is calculated as daily cash flow from operating activities, adjusted for non-cash charges and interest. This metric provides continuous monitoring of operational efficiency between quarterly reports, eliminating the risk of sudden drawdowns. For Tyra Biosciences, Inc. (TYRA), this is a critical tool for controlling R&D costs during the development of FGFR inhibitors. By analyzing the EBITDA_Co trend on the GURU.Markets platform, investors can assess the capital burn rate ahead of key FDA milestones.

Analisis pesaing Tyra Biosciences, Inc.

Genmab Corp (GMAB) - Bathi sadurunge bunga, pajak, lan amortisasi|EXEL: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NUVL (nuvalent.com)|KYMR (Kymera) - Bathi operasional sadurunge ngurangi amortisasi|IDYA: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|ELVN (Enliven Pharma) - Bathi operasional EBITDA|Bathi operasional EBITDA ORIC Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Relay Therapeutics (RLAY)|NRIX (nurixtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA VSTM (Verastem)|Bathi operasional sadurunge potongan amortisasi Monte Rosa Therapeutics Inc|Cullinan Therapeutics Inc - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Immuneering Corp.|CCCC (C4 Therapeutics, Inc.) - Bathi operasional sadurunge ngurangi amortisasi|BDTX: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|RPTX (Repare Therapeutics Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi PMV Pharmaceuticals Inc. PMVP|Bathi operasional EBITDA KPTI|propanc.com - Bathi operasional sadurunge amortisasi|Bio Green Med Solution Inc - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi AADI|ALRN: Bathi operasional sadurunge ngurangi amortisasi|Blueprint Medicines - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|GLYC: Bathi operasional EBITDA|SpringWorks Therapeutics, Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi